DIAZEPAM (DIAZEPAM) — FDA Approval ANDA214745 (FRESENIUS KABI USA)
DIAZEPAM (DIAZEPAM) — FDA Approval ANDA214745 (FRESENIUS KABI USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DIAZEPAM; Active ingredients: DIAZEPAM; Application number: ANDA214745.
| Brand name | DIAZEPAM |
|---|---|
| Active ingredients | DIAZEPAM |
| Application number | ANDA214745 |
| Sponsor | FRESENIUS KABI USA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20221110 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →